With 5th Circuit’s Temporary Block of Abortion Pill by Mail, Louisiana v. FDA Might Get SCOTUS Review

0
143

On Friday, the Fifth Circuit United States Court of Appeals issued a ruling in the case of Louisiana v. FDA, which rendered a major blow to the abortion industry. The Fifth Circuit temporarily blocked the 2023 changes the Food and Drug Administration (FDA) made to its risk evaluation and mitigation strategy (REMS) rule, which allowed the abortion pill Mifepristone to be distributed over the counter and by mail, without medical safeguards or supervision.

LA’s Attorney General Liz Murrill shares the “victory for Life” on social media:

Read more…

LEAVE A REPLY

Please enter your comment!
Please enter your name here